NCT04974385View on ClinicalTrials.gov

Liposomal Bupivacaine Versus Non-liposomal Bupivacaine for Total Shoulder Arthroplasty

PHASE3CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

August 4, 2021

Primary Completion Date

April 30, 2022

Study Completion Date

May 4, 2022

Conditions
Analgesia
Interventions
DRUG

Liposomal bupivacaine

Validate the analgesic efficacy of admixed LB + bupivacaine compared with plain bupivacaine when injected for ISNB for total shoulder arthroplasty.

DRUG

Bupivacaine

Active comparator as standard of care.

Trial Locations (1)

22903

University of Virginia Medical Center, Charlottesville

All Listed Sponsors
lead

University of Virginia

OTHER

NCT04974385 - Liposomal Bupivacaine Versus Non-liposomal Bupivacaine for Total Shoulder Arthroplasty | Biotech Hunter | Biotech Hunter